在开放的微流控系统中集成微结构电纺支架，用于体外研究人类患者衍生的原代细胞,ACS Biomaterials Science & Engineering - X-MOL
Διαμαντής Λ. Μισιτζής MD - Página inicial | Facebook
PDF) The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
George DEDOUSSIS | Professor of cellular and molecular biology | PhD | Harokopio University, Kallithéa | HUA | Department of Nutrition and Dietetics - Page 5
Summary of recent and ongoing adjuvant chemotherapy trials | Download Table
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
Eftychia Lekka - Senior Investigator, Drug Discovery - Biovista | LinkedIn
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
A) On low power examination, MPC is more cellular peripherally (red... | Download Scientific Diagram
CANCER IMMUNOSCORING | Sonia A Perez | 2 updates | 11 publications | Research Project
Percentage (range) of ER-Positive Cells and Mean Fluorescence Channel... | Download Scientific Diagram
Georgios PISSAKAS | Alexandra Regional General Hospital, Athens | Department of Radiation Oncology
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
μικροχειρουργική – Διαμαντής Λ. Μισιτζής
CD4 + CD161 + cells stimulated via CD3/CD28 suppress autologous PBMC... | Download Scientific Diagram
CEACAM19 mRNA expression in paired breast tissue samples. Black boxes... | Download Scientific Diagram
PDF) Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
![Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram](https://www.researchgate.net/profile/Panteleimon-Kountourakis/publication/43132163/figure/fig2/AS:330189788729344@1455734788034/Patients-with-pathological-response-have-longer-TTR-48-months-17-84-than-patients.png "Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram")
Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram
Relative quantification of the CEACAM19 expression via real-time PCR.... | Download Scientific Diagram
Psychosocial Adjustment to Illness Scale: Factor structure, reliability, and validity assessment in a sample of Greek breast cancer patients: Women & Health: Vol 57, No 6
Identification of novel breast cancer‐associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells - Laversin - 2013 - Genes, Chromosomes and Cancer - Wiley Online Library
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
Comparison by flow cytometric analysis of estrogen receptor expression... | Download Scientific Diagram
Study design of the ADEBAR study. | Download Scientific Diagram
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
PDF) Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: A multimodality approach for locally advanced breast cancer
Διαμαντής Λ. Μισιτζής MD - Página inicial | Facebook
